Related Experiment Video

Updated: Apr 23, 2026

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
06:50

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms

Published on: September 16, 2022

2.8K

Fungal biofilms, drug resistance, and recurrent infection

Jigar V Desai1, Aaron P Mitchell1, David R Andes2

  • 1Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213.

Cold Spring Harbor Perspectives in Medicine
|October 3, 2014
PubMed

Insights

Fungal biofilms, surface-associated microbial communities, are a major cause of recurrent infections, especially on implanted devices. Understanding fungal biofilm formation and drug resistance is crucial for effective treatment.

Area of Science:

  • Microbiology
  • Infection Biology
  • Mycology

Background:

  • Biofilms are surface-associated microbial communities formed by diverse fungi.
  • Fungal biofilm formation is a significant factor in infection biology.
  • These biofilms contribute to recurrent infections and pose treatment challenges.

Purpose of the Study:

  • To summarize current knowledge on fungal biofilm formation.
  • To review the genetic control mechanisms of fungal biofilms.
  • To elucidate the basis of drug resistance in fungal biofilms.

Main Methods:

  • Literature review of fungal biofilm research.
  • Analysis of genetic regulation in fungal biofilm development.
  • Investigation into mechanisms of antifungal drug resistance in biofilms.

Main Results:

  • Fungal biofilms are implicated in device-associated and non-device-associated infections.
  • Specific genetic pathways govern fungal biofilm development.
  • Biofilms exhibit inherent resistance to antifungal drugs.

Conclusions:

  • Fungal biofilms present a significant challenge in treating infections.
  • Further research into genetic control and resistance mechanisms is needed.
  • Targeting biofilm formation and resistance pathways may improve therapeutic outcomes.

More Related Videos

Candida albicans Biofilm Chip CaBChip for High-throughput Antifungal Drug Screening08:05

Candida albicans Biofilm Chip CaBChip for High-throughput Antifungal Drug Screening

Published on: July 18, 2012

13.1K
Passaging HuES Human Embryonic Stem Cell-lines with Trypsin.09:38

Passaging HuES Human Embryonic Stem Cell-lines with Trypsin.

Published on: October 12, 2006

258.8K

Related Concept Videos

Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
2.0K
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
110
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
770
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
182